MedTrace Logo

Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery

NCT05258617 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2022-11-28

No results posted yet for this study

Summary

An informational evaluation of COVID-19 patients who receive low-level laser therapy in addition to a normal regimen of treatment for symptoms associate with COVID-19. Results are compared to statistical observations published in literature from patients receiving standard care for COVID-19 symptoms without low-level laser therapy.

Conditions

  • COVID-19
  • Acute Respiratory Distress Syndrome

Interventions

DEVICE

LLLT Photobiomodulation

Treatment with red LED light using UltraSlim device.

Sponsors & Collaborators

  • Ward Photonics LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-24
Primary Completion
2022-11-21
Completion
2022-11-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05258617 on ClinicalTrials.gov